Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Surg Pathol Clin. 2024 Dec;17(4):599-614. doi: 10.1016/j.path.2024.07.002. Epub 2024 Sep 10.
The sinonasal tract, while an uncommon site of SCC overall, is another "hot spot" for transcriptionally-active high-risk HPV-associated tumors. The accumulating data show that, across the world, the rate of HPV-associated SCC here is approximately 15% and, in the United States, closer to 30%. Patients have lower disease recurrence and better survival than HPV-independent SCC patients. Low-risk HPV also causes a smaller subset of sinonasal SCC, mostly through exophytic and inverted papillomas that transform into SCC. It is not known if these patients have better survival than patients with low-risk HPV-negative SCC. This article reviews the latest data on HPV in sinonasal tumors.
鼻腔鼻窦通道虽然总体来说不是 SCC 的常见部位,但却是另一个转录活跃的高危 HPV 相关肿瘤的“热点”。不断增加的数据表明,在全球范围内,此处 HPV 相关 SCC 的比例约为 15%,而在美国则接近 30%。与 HPV 不相关的 SCC 患者相比,这些患者的疾病复发率更低,生存率更高。低危型 HPV 也会导致一小部分鼻腔鼻窦 SCC,主要通过外生性和内翻性乳头状瘤转化为 SCC。目前尚不清楚这些患者的生存率是否高于低危型 HPV 阴性 SCC 患者。本文综述了 HPV 在鼻腔鼻窦肿瘤中的最新数据。